company background image
A

Agilent TechnologiesNYSE:A Stock Report

Last Price

US$144.68

Market Cap

US$43.7b

7D

-0.3%

1Y

14.6%

Updated

17 Jan, 2022

Data

Company Financials +
A fundamental analysis
Snowflake Score
Valuation1/6
Future Growth2/6
Past Performance5/6
Financial Health5/6
Dividends0/6

A Stock Overview

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide.

Agilent Technologies Competitors

Thermo Fisher Scientific

NYSE:TMO

US$234.4b

Danaher

NYSE:DHR

US$209.6b

Illumina

NasdaqGS:ILMN

US$63.3b

Mettler-Toledo International

NYSE:MTD

US$34.8b

Price History & Performance

Summary of all time highs, changes and price drops for Agilent Technologies
Historical stock prices
Current Share PriceUS$144.68
52 Week HighUS$179.57
52 Week LowUS$112.47
Beta1.0
1 Month Change-4.45%
3 Month Change-7.03%
1 Year Change14.63%
3 Year Change101.14%
5 Year Change205.30%
Change since IPO238.43%

Recent News & Updates

Jan 10
Is Now An Opportune Moment To Examine Agilent Technologies, Inc. (NYSE:A)?

Is Now An Opportune Moment To Examine Agilent Technologies, Inc. (NYSE:A)?

Today we're going to take a look at the well-established Agilent Technologies, Inc. ( NYSE:A ). The company's stock...

Dec 16
Does Agilent Technologies (NYSE:A) Have A Healthy Balance Sheet?

Does Agilent Technologies (NYSE:A) Have A Healthy Balance Sheet?

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...

Nov 28
Does This Valuation Of Agilent Technologies, Inc. (NYSE:A) Imply Investors Are Overpaying?

Does This Valuation Of Agilent Technologies, Inc. (NYSE:A) Imply Investors Are Overpaying?

How far off is Agilent Technologies, Inc. ( NYSE:A ) from its intrinsic value? Using the most recent financial data...

Shareholder Returns

AUS Life SciencesUS Market
7D-0.3%-3.3%-0.3%
1Y14.6%9.6%13.7%

Return vs Industry: A exceeded the US Life Sciences industry which returned 9.6% over the past year.

Return vs Market: A matched the US Market which returned 13.7% over the past year.

Price Volatility

Is A's price volatile compared to industry and market?
A volatility
A Average Weekly Movement3.4%
Life Sciences Industry Average Movement8.7%
Market Average Movement6.6%
10% most volatile stocks in US Market15.9%
10% least volatile stocks in US Market2.4%

Stable Share Price: A is less volatile than 75% of US stocks over the past 3 months, typically moving +/- 3% a week.

Volatility Over Time: A's weekly volatility (3%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
199917,000Mike McMullenhttps://www.agilent.com

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment provides arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, gene expression profiling, next generation sequencing, target enrichment and genetic data management, and interpretation support software; and produces synthesized oligonucleotide.

Agilent Technologies Fundamentals Summary

How do Agilent Technologies's earnings and revenue compare to its market cap?
A fundamental statistics
Market CapUS$43.69b
Earnings (TTM)US$1.21b
Revenue (TTM)US$6.32b

36.1x

P/E Ratio

6.9x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
A income statement (TTM)
RevenueUS$6.32b
Cost of RevenueUS$2.91b
Gross ProfitUS$3.41b
ExpensesUS$2.20b
EarningsUS$1.21b

Last Reported Earnings

Oct 31, 2021

Next Earnings Date

Feb 22, 2022

Earnings per share (EPS)4.01
Gross Margin53.92%
Net Profit Margin19.15%
Debt/Equity Ratio50.6%

How did A perform over the long term?

See historical performance and comparison

Dividends

0.6%

Current Dividend Yield

19%

Payout Ratio

Valuation

Is Agilent Technologies undervalued compared to its fair value and its price relative to the market?

36.11x

Price to Earnings (PE) ratio


Share Price vs. Fair Value

Below Fair Value: A ($144.68) is trading above our estimate of fair value ($138.62)

Significantly Below Fair Value: A is trading above our estimate of fair value.


Price To Earnings Ratio

PE vs Industry: A is good value based on its PE Ratio (36.1x) compared to the US Life Sciences industry average (39.9x).

PE vs Market: A is poor value based on its PE Ratio (36.1x) compared to the US market (17.4x).


Price to Earnings Growth Ratio

PEG Ratio: A is poor value based on its PEG Ratio (4.5x)


Price to Book Ratio

PB vs Industry: A is overvalued based on its PB Ratio (8.1x) compared to the US Life Sciences industry average (3.3x).


Future Growth

How is Agilent Technologies forecast to perform in the next 1 to 3 years based on estimates from 15 analysts?

8.0%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: A's forecast earnings growth (8% per year) is above the savings rate (2%).

Earnings vs Market: A's earnings (8% per year) are forecast to grow slower than the US market (13% per year).

High Growth Earnings: A's earnings are forecast to grow, but not significantly.

Revenue vs Market: A's revenue (6.2% per year) is forecast to grow slower than the US market (9.3% per year).

High Growth Revenue: A's revenue (6.2% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: A's Return on Equity is forecast to be high in 3 years time (26.6%)


Past Performance

How has Agilent Technologies performed over the past 5 years?

16.7%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: A has high quality earnings.

Growing Profit Margin: A's current net profit margins (19.1%) are higher than last year (13.5%).


Past Earnings Growth Analysis

Earnings Trend: A's earnings have grown by 16.7% per year over the past 5 years.

Accelerating Growth: A's earnings growth over the past year (68.3%) exceeds its 5-year average (16.7% per year).

Earnings vs Industry: A earnings growth over the past year (68.3%) underperformed the Life Sciences industry 72.2%.


Return on Equity

High ROE: A's Return on Equity (22.5%) is considered high.


Financial Health

How is Agilent Technologies's financial position?


Financial Position Analysis

Short Term Liabilities: A's short term assets ($3.8B) exceed its short term liabilities ($1.7B).

Long Term Liabilities: A's short term assets ($3.8B) exceed its long term liabilities ($3.6B).


Debt to Equity History and Analysis

Debt Level: A's net debt to equity ratio (21.4%) is considered satisfactory.

Reducing Debt: A's debt to equity ratio has increased from 44.9% to 50.6% over the past 5 years.

Debt Coverage: A's debt is well covered by operating cash flow (54.4%).

Interest Coverage: A's interest payments on its debt are well covered by EBIT (17.8x coverage).


Balance Sheet


Dividend

What is Agilent Technologies's current dividend yield, its reliability and sustainability?

0.58%

Current Dividend Yield


Dividend Yield vs Market

Notable Dividend: A's dividend (0.58%) isn’t notable compared to the bottom 25% of dividend payers in the US market (1.32%).

High Dividend: A's dividend (0.58%) is low compared to the top 25% of dividend payers in the US market (3.44%).


Stability and Growth of Payments

Stable Dividend: A is not paying a notable dividend for the US market, therefore no need to check if payments are stable.

Growing Dividend: A is not paying a notable dividend for the US market, therefore no need to check if payments are increasing.


Current Payout to Shareholders

Dividend Coverage: A is not paying a notable dividend for the US market.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of A's dividend in 3 years as they are not forecast to pay a notable one for the US market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

7.0yrs

Average management tenure


CEO

Mike McMullen (60 yo)

7.33yrs

Tenure

US$13,610,481

Compensation

Mr. Michael R. McMullen, also known as Mike, has been the President of Agilent Technologies, Inc., since September 17, 2014 and Chief Executive Officer since March 18, 2015. Mr. McMullen has been a Directo...


CEO Compensation Analysis

Compensation vs Market: Mike's total compensation ($USD13.61M) is about average for companies of similar size in the US market ($USD11.18M).

Compensation vs Earnings: Mike's compensation has been consistent with company performance over the past year.


Leadership Team

Experienced Management: A's management team is seasoned and experienced (7 years average tenure).


Board Members

Experienced Board: A's board of directors are considered experienced (6.3 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: A insiders have only sold shares in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Agilent Technologies, Inc.'s employee growth, exchange listings and data sources


Key Information

  • Name: Agilent Technologies, Inc.
  • Ticker: A
  • Exchange: NYSE
  • Founded: 1999
  • Industry: Life Sciences Tools and Services
  • Sector: Pharmaceuticals & Biotech
  • Implied Market Cap: US$43.693b
  • Shares outstanding: 302.00m
  • Website: https://www.agilent.com

Number of Employees


Location

  • Agilent Technologies, Inc.
  • 5301 Stevens Creek Boulevard
  • Santa Clara
  • California
  • 95051
  • United States

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2022/01/17 23:13
End of Day Share Price2022/01/14 00:00
Earnings2021/10/31
Annual Earnings2021/10/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.